IP3R Antibodies

Santa Cruz Biotechnology features a diverse variety of IP3R monoclonal antibodies for advanced research in cellular signaling pathways. IP3R Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Inositol trisphosphate receptors (IP3Rs) play a crucial role in calcium signaling by mediating the release of calcium ions from the endoplasmic reticulum in response to inositol trisphosphate. This calcium release is essential for numerous cellular processes, including muscle contraction, neurotransmitter release, and cell proliferation. Understanding IP3Rs is vital for elucidating their involvement in various physiological and pathological conditions, including cardiac function and neurodegenerative diseases. IP3R monoclonal antibodies enable researchers to investigate calcium signaling mechanisms across multiple experimental approaches. Studying IP3Rs contributes significantly to understanding cellular communication and regulation. Research utilizing IP3R monoclonal antibodies helps advance knowledge of disease mechanisms and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular signaling pathways and their impact on human health.